Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Phil Cressman who wrote (1250)	7/7/1998 4:24:00 PM
From: Rudy Saucillo	Read Replies (2) of 2742

Steve, News release puts valuation at 46 cents per share. Phil, Book value is 48 cents/share. The Pasteur Merieux Connaught deal, with potential for $31mm in milestone payments, ~$1mm equity investment in CIST, and funding for preclinical research will clearly drive CIST value substantially higher. There's also still the potential for additional partnerships for other IL-1b applications. The selloff, while expected given the number of frustrated investors, surprised me by its magnitude. Why would anyone sell below book after announcement of a major agreement with the world's preeminent vaccine maker??? Once the selling is done - and I believe it will be fairly quick - I would expect recovery to the mid-60's and higher. I'm pleased and optimistic! Rudy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next